Nutritional status of patients with acquired immunodeficiency syndrome. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Nutritional status of patients with acquired immunodeficiency syndrome.

Clin Chem. 1988 Oct;34(10):1957-9. Unique Identifier : AIDSLINE MED/89003517
Huang CM; Ruddel M; Elin RJ; Clinical Pathology Department, Warren Grant Magnuson Clinical; Center, National Institutes of Health, Bethesda, MD 20892.

Abstract: Nutritional status may be an important factor in the prognosis of morbidity and mortality. We assessed the nutritional status of individuals seropositive for human immunodeficiency virus (HIV) (as confirmed by Western blot) and of patients with AIDS, by determining the concentration in serum of total protein, albumin, prealbumin (transthyretin), and retinol-binding protein. HIV-seropositive individuals showed no significant difference from normal volunteers in values for prealbumin, albumin, and retinol-binding protein. Patients with AIDS showed significantly smaller prealbumin and albumin concentrations than did normal and HIV-positive individuals. There was no significant difference in the concentration of retinol-binding protein among the three groups. The concentration of total serum protein was significantly greater in HIV-positive individuals and in patients with AIDS than in normal individuals. Thus, the nutritional status of patients with AIDS may be a factor for morbidity and mortality.
Keywords: Acquired Immunodeficiency Syndrome/*PHYSIOPATHOLOGY Human HIV Seropositivity *Nutritional Status Prealbumin/BLOOD Retinol-Binding Proteins/BLOOD Serum Albumin/ANALYSIS JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDphysiopathologyhumanhivseropositivityKWDnutritionalstatusprealbumin/bloodretinol-bindingproteins/bloodserumalbumin/analysisjournalarticle
890130
M8910498

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .